Skip to main content
. 2020 Nov 23;6(2):100621. doi: 10.1016/j.adro.2020.11.006

Figure 1.

Figure 1

Local recurrence (LR) of patients with pancreatic ductal adenocarcinoma with (red) or without (blue) fiducial before stereotactic body radiation therapy. There was no significant difference between both groups with regard to LR (adjusted hazard ratio = 0.6, 95% CI 0.3-1.3, P = .59).